A multicenter, randomized, double-blind, placebo controlled study of aripiprazole monotherapy in the treatment of acutely manic patients with bipolar I disorder
Latest Information Update: 12 Nov 2013
At a glance
- Drugs Aripiprazole (Primary) ; Haloperidol
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 01 Jan 2009 Results have been published in the British Journal of Psychiatry.
- 03 May 2008 Results have been presented at the 161st Annual Meeting of the American Psychiatric Association.
- 31 Jul 2007 Status change from in progress to completed